Services

Healthcare AI, SaMD,NHS assurance andmarket access capability.

From AI readiness and NHS digital health assurance to medical device evidence and multi-market expansion, Neural Vibe supports suppliers and healthcare organisations through one accountable advisory model.

We build

Choose your route

Start with the pressure you are actually feeling.

The fastest path through compliance is not a catalogue. It is a decision sequence: what are you trying to prove, to whom, and what evidence unlocks the next move?

Market access

You need the credible route before the product story hardens.

Clarify intended purpose, claims, classification and evidence so the next commercial move is built on a defensible regulatory path.
  1. Define the product
  2. Map the market route
  3. Build the evidence plan
Shape market access

Capability index

Built around the way regulated software, AI and digital health reach market and adoption.

Strategy, technical evidence, management systems and specialist workstreams connected into one delivery model.

Healthcare AI and NHS assurance

Advisory support for teams developing, selecting or deploying AI and digital health.

AI readiness, governance, DTAC, clinical safety, NHS information governance and assurance planning for suppliers and healthcare organisations.

SaMD and AIaMD first

The first decision is what you are really taking to market.

Claims, intended purpose, users, clinical context, model behaviour and software boundaries shape everything that follows. Neural Vibe starts there, then builds the evidence system around the route.

Discuss your product
01

Define the regulated product

Clarify intended purpose, claims, users, clinical context, software boundaries and whether the product is SaMD, AIaMD or adjacent health technology.

02

Choose the route to market

Map UK, EU, US and international routes, identify assessment bodies, confirm evidence expectations and sequence work around funding and launch goals.

03

Build the evidence system

Create the technical, clinical, risk, software, security, AI governance and quality evidence that supports the chosen route.

04

Coordinate specialists

Bring in clinical, security, legal, notified body, FDA, international or implementation specialists where the project needs deeper support.

05

Sustain market access

Keep post-market surveillance, change control, security, model monitoring and renewals aligned as the product scales.

Markets

One evidence base, multiple regulatory conversations.

United Kingdom

UK market access and NHS readiness

Bring software and AI health products into the UK market and NHS settings with the regulatory, clinical safety and buyer evidence expected for adoption.
  • UK MDR 2002 classification and UKCA marking
  • DTAC and NHS buyer evidence
  • DCB 0129 clinical risk management
  • Information governance, privacy and security assurance
  • Approved Body liaison and conformity assessment support

European Union

EU MDR, CE marking and the EU AI Act

Connect medical device conformity assessment with the new obligations the EU AI Act introduces for high-risk AI-enabled medical products.
  • EU MDR 2017/745 classification and technical documentation
  • EU AI Act high-risk readiness
  • Notified Body strategy and submission support
  • Clinical evaluation and post-market surveillance
  • Authorised Representative and market entry planning

United States

FDA pathway strategy and submissions

Identify the right FDA route and prepare software, clinical, risk and quality evidence that supports a credible US submission.
  • 510(k) substantial equivalence strategy
  • De Novo pathway planning
  • PMA readiness for high-risk products
  • QMSR and quality system alignment
  • SaMD and AI-enabled device evidence expectations

International

Multi-market expansion without rebuilding everything

Reuse a strong evidence base for Canada, Australia, Brazil and other target markets, with local requirements managed in the right order.
  • Health Canada licensing and MDSAP planning
  • TGA registration and ARTG inclusion
  • ANVISA registration support
  • Multi-jurisdiction roadmap and evidence reuse
  • Local representation and regulatory liaison

ISO and assurance

ISO management systems, implemented end to end.

Neural Vibe designs, implements, embeds and maintains the management systems that regulated health technology companies need to win trust, pass audits, satisfy buyers and keep improving after certification.

Design the system

Define scope, objectives, process architecture, policies, controls, roles, registers and the evidence model around how the client actually works.

Implement and embed

Turn the system into day-to-day routines: risk review, supplier review, change control, document control, incident handling, competence, objectives and operational evidence.

Prepare for external audit

Run readiness reviews, close gaps, prepare audit evidence, brief the team and sit with the client through Stage 1, Stage 2 or external assessment activity.

Support certification and beyond

Represent the client during certification and surveillance visits, then support internal audits, management reviews, supplier reviews, risk reviews and continual improvement.

Start here

Not sure which standards apply to you?

That is the most common place to start. We will map the product, the market and the evidence path before you spend months in the wrong workstream.

Book a discovery call